Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02392364 · ClinicalTrials.gov registry record · Phase 4
Variable Interval Versus Set Interval Aflibercept for DME
A Phase 4 study, sponsored by California Retina Consultants.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT02392364: Completed Phase 4 study, sponsored by California Retina Consultants.
NCT02392364 is a Phase 4 study that has completed, run by California Retina Consultants. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02392364, a Phase 4 study, has completed, sponsored by California Retina Consultants.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the safety and efficacy of intravitreal Eylea injections at a set interval, versus a variable dosing schedule (likely longer than one month), based on a specific individual's disease progression. There will be approximately 50 men and women at least 18 years of age, diagnosed with type 1 or type 2 diabetes, taking part in this study at 5 locations in the United States.
Primary Outcome
Change in mean BCVA from baseline to week 52
Interventions
- DRUG Intravitreal Aflibercept Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2015-04-15 |
| Est. Completion | 2018-11-15 |
| Phase | Phase 4 |
What the finished NCT02392364 record still lists
NCT02392364 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Intravitreal Aflibercept Injection is the first listed.
NCT02392364 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02392364 about?
NCT02392364 is a clinical study titled "Variable Interval Versus Set Interval Aflibercept for DME". The purpose of this study is to compare the safety and efficacy of intravitreal Eylea injections at a set interval, versus a variable dosing schedule (likely longer than one month), based on a specific individual's disease progression. There will be approximately 50 men and women at least 18 years o...
What is the current status of trial NCT02392364?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2015-04-15. Estimated completion is 2018-11-15.
What interventions are being tested in trial NCT02392364?
The interventions under investigation include: Intravitreal Aflibercept Injection (DRUG).
Who is sponsoring clinical trial NCT02392364?
This trial is sponsored by California Retina Consultants, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02392364's enrollment target sits among peer trials
50 1255th of 2000 higher than 678 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI